Wilmer Cutler Pickering Hale and Dorr LLP advised Volastra Therapeutics on the deal.Volastra Therapeutics, a biotechnology company developing novel therapies for the prevention and treatment of…
Volastra Therapeutics’ Extended $44M Seed Financing


Wilmer Cutler Pickering Hale and Dorr LLP advised Volastra Therapeutics on the deal.Volastra Therapeutics, a biotechnology company developing novel therapies for the prevention and treatment of…
…